期刊文献+

甲状腺转录因子在甲状腺良恶性病变中的表达 被引量:4

Expression of Thyroid Transcription Factor in Benign and Malignant Thyroid Diseases
下载PDF
导出
摘要 [目的]探讨甲状腺转录因子 (TTF_1)在甲状腺常见良恶性病变中的表达情况 ,并与甲状腺球蛋白(TG)和降钙素(CT)进行比较。[方法]采用Envision二步免疫组织化学分析法分别检测TTF 1和TG在45例常见的甲状腺良性病变和65例甲状腺癌中的表达 ,其中10例甲状腺髓样癌加做CT检测。[结果]TTF 1为核阳性 ,TG和CT为胞浆阳性。甲状腺滤泡细胞起源的良性病变TTF 1和TG阳性率均为100.0 % (45/45) ;而相应的恶性肿瘤TTF 1和TG的阳性率分别为89.1% (49/55)和85.5 % (47/55)。起源于甲状腺滤泡旁C细胞的髓样癌TTF 1阳性率为70.0 % (7/10) ,CT和TG阳性率分别为100.0 % (10/10)和0(0/10)。[结论]TTF 1在甲状腺常见良恶性病变中阳性率高 ,因其特异地表达在细胞核 ,是一种很好的甲状腺滤泡细胞和滤泡旁C细胞特异性标记物。 Purpose To investigate the expression of thyroid transcription factor_ 1( TTF-1) protein in benign and malignant thyroid diseases, and compared with those of thyroglobulin calcitoinin(TG)and(CT). TG and TTF-1 expression were detected by Envision technique in 45 specimens of benign thyroid diseases and 65 specimens of malignant thyroid neoplasms, and CT protein was also detected in 10 specimens of medullary carcinomas. TTF-1 were expressed in the nuclei of follicular cells and parafollicular C cells, whereas TG and CT were expressed in the cytoplasm of follicular and parafollicular C cells. TG and TTF-1 were both 100.0%(45/45) positive in follicular cells of benign thyroid diseases, and were 89.1%(49/55) and 85.5%(47/55) positive in malignant thyroid neoplasms respectively.In medullary carcinoma,positive rates of TTF-1, CT and TG were 70.0%(7/10), 100.0%(10/10)and 0(0/10) respectively. [Conclusion]TTF-1 were expressed in the majority of benign and malignant thyroid diseases. The immunostainning of TTF-1 was located in nuclear of cells.TTF-1 was a sensitive marker for thyroid follicular cells and parafollicular C cells.
出处 《肿瘤学杂志》 CAS 2003年第1期19-20,共2页 Journal of Chinese Oncology
关键词 甲状腺转录因子 甲状腺球蛋白 降钙素 甲状腺疾病 甲状腺癌 thyroid transcription factor_1 thyroglobulin calcitoinin thyroid disease
  • 相关文献

参考文献6

  • 1[1]Bejarano PA,Baughman RP,Biddinger PW,et al.Surgactant proteins and thyroid transcription factor 1 in pulmonary and breast carcinomas[J].Mod Pathol, 1996,9445-9452.
  • 2[2]Fabio P,Fabio B,Damante G,et al. Prognostic value of thyroid transcription factor 1 in primary, resected,non small cell lung carcinoma[J].Mod Pathol, 1999,12:318-324.
  • 3[3]Bejarano PA,Niliforov YE, Swenson ES,et al.Thyroid transcription factor 1, throglobulin, cytokeratin 7,and cytokeratin 20 in thyroid neoplasms[J]. Appl Immunohistochem Mol Morphol,2000,8(3):189-194.
  • 4[4]Katoh R,Kawaoi A,Miyagi E,et al. Thyroid transcription factor 1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization[J].Mod Pathol,2000,13:570-576.
  • 5[5]Ros P,Rossi DL.Thyroid specific gene expression in the multi step process of thyroid carcinogensis[J].Biochem,1999,81:389-396.
  • 6[6]Katoh R,Miyagi E,Nakamura N,et al. Expression of thyroid transcription factor 1(TTF 1) in human C cells and medullary throid carcinomas[J]. Hum Pathol, 2000,31: 386-393.

同被引文献46

  • 1殷凯,张筱骅,王瓯晨,闫东升,陈晓燕,李权.甲状腺乳头状癌钠碘同向转运体基因启动子区域CpG岛异常甲基化状态检测及其意义[J].浙江医学,2009(11). 被引量:2
  • 2李咏梅,曹芳,曹新.乳腺癌RASSF1A基因表达及启动子区甲基化研究[J].南京医科大学学报(自然科学版),2006,26(7):496-500. 被引量:9
  • 3李敏,黄在菊,董卫红,李晓艳,王晓翊,贺晓红,王瀚,王泽华.卵巢上皮性癌组织中p16INK4A基因表达缺陷的意义及其与甲基化的关系[J].中华妇产科杂志,2006,41(6):408-412. 被引量:8
  • 4Handkiewicz-Junak D, Czarniecka A, Jarzab B. Molecular prognostic markers in papillary and follicular thyroid can- cer: current status and future directions [J]. Mol Cell En- doerinol, 2010, 322(1-2) :8-28.
  • 5Latif R, Morshed SA, Zaidi M, et al. The thyroid-stimu- lating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor anti- bodies on multimerization, cleavage, and signaling[J]. En- docrinol Metab Clin North Am, 2009, 38(2):319-341.
  • 6Neumann S, Raaka BM, Gershengorn MC. Human TSH receptor ligands as pharmacological probes with potential clinical application [J]. Expert Rev Endocrinol Metab, 2009, 4(6):669-679.
  • 7Smith JA, Fan CY, Zou C, et al. Methylation status of genes in papillary thyroid carcinoma [J]. Arch Otolaryngol Head Neck Surg, 2007, 133(10):1006-1011.
  • 8Khoo TK, Bahn RS. Pathogenesis of Graves ophthalmopa- thy: the role of autoantibodies [J]. Thyroid, 2007, 17(10): 1013-1018.
  • 9Kursawe R, Paschke R. Modulation of NIS signaling by posttranslational modifications [J]. Trends Endocrinol Metab, 2007, 18(5):199-207.
  • 10De Smet C, Loriot A. DNA hypomethylation in cancer: epigenetic scars of a neoplastic journey [J]. Epigenetics, 2010, Apr 10.[Epub ahead of print].

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部